Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

high-risk prostate cancer; androgen receptor axis; castration resistance; neuroendocrine carcinoma; PARP inhibition; immunotherapy; cancer genome; precision targeting; robot-assisted partial nephrectomy; renal cell carcinoma; indocyanine green; nephron sparing; prostate cancer survivors; follow-up care; primary health care; general practice; process evaluation; Consolidated Framework for Implementation Research; prostate-specific membrane antigen positron-emission tomography; multiparametric magnetic-resonance imaging; primary diagnosis; prostate cancer; systematic review; diagnosis; PSMA; PSA; tumor; PET scan; bladder cancer; bisphenol A; bisphenol S; energy metabolism; migration; proliferation; carbon-ion radiotherapy; elderly patients; radiotherapy; particle beam therapy; life expectancy; systemic immune-inflammation index; Charlson comorbidity index; CAPRA-S; early survival; male incontinence; robotic prostatectomy; clear cell renal cell carcinoma; ferroptosis; prognostic model; TCGA; E-MTAB-1980; GLS2; pazopanib; real-world data; non-interventional study; time on drug; nivolumab; everolimus; trial-eligibility; ureteral neoplasms; urinary bladder neoplasms; ureteroscopy; CNTF; CNTFRα; LNCaP; 22Rv1; castration resistant; castration sensitive; STAT3; ERK; MMP; biomarker; Gleason grade; transforming growth factor-β family; activin; INHBA; INHBB; INHBC; prostate-specific antigen; false-positive results; real world-data; n/a